Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 36 h ago

Opus Genetics, Inc.: PERCEPTIVE ADVISORS LLC amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Perceptive Advisors LLC amended its Schedule 13G filing on Opus Genetics Inc., updating its beneficial ownership stake with the SEC under accession number 0001193125-26-463810. The amendment signals a change in the investment firm's position in the clinical-stage gene therapy developer, though the filing did not disclose the revised share count or percentage in the headline. Schedule 13G amendments are typically filed by passive investors when their ownership crosses the 5% threshold or when previously reported holdings change materially. Investors will watch for the full filing details to gauge whether Perceptive increased or trimmed its exposure to Opus.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Perceptive Advisors LLC, Opus Genetics, Inc.